Detoxication of aflatoxin B1 as a model for carcinogen metabolism

In Vitro and Molecular Toxicology: Journal of Basic and Applied Research

Volumn 11, Issue 1, 1998, Pages 95-101

  Langouët, Sophie ^a   Johnson, William W ^b   Guillouzo, André ^a   Guengerich, F Peter ^b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CARCINOGEN; CYTOCHROME P450; EPOXIDE; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; ISOTHIOCYANIC ACID DERIVATIVE; OLTIPRAZ;

CATALYSIS; CONFERENCE PAPER; DETOXIFICATION; HUMAN; HUMAN CELL; HYDROLYSIS; LIVER CARCINOGENESIS; LIVER CELL CULTURE; METABOLISM; NONHUMAN;

EID: 0031830883     PISSN: 10979336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. 1 induces the transversion of G to T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci. USA 90, 8586-8590.
2. 1: the ultimate carcinogenic species. J. Am. Chem. Soc. 110, 7929-7931.
3. BARCELO, S., GARDINER, J.M., GESCHER, A., and CHIPMAN, J.K. (1996). CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17, 277-282.
4. DAVIDSON, N.B., EGNER, P.A., and KENSLER, T.W. (1990). Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res. 50, 2251-2255.
5. EGNER, P.A., KENSLER, T.W., PRESTERA, T., et al. (1994). Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 15, 177-181.
6. 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res. 32, 2058-2062.
7. GUILLOUZO, A., MOREL, F., LANGOUËT, S., MAHEO, K., and RISSEL, M. (1997). Use of hepatocyte cultures for the study of hepatotoxic compounds. J. Hepatol. 26, 73-80.
8. 1: Mechanistic studies. J. Am. Chem. Soc. 116, 1603-1609.
9. JACOBSON, L.P., ZHANG, B.C., ZHU, Y.R., et al. (1997). Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes. Cancer Epidemiol. Biomarkers Prev. 6, 257-265.
10. 1 exo-8,9-oxide and rearrangement of the dihydrodiol. J. Am. Chem. Soc. 118, 8213-8220.
11. 1 exo-8,9-epoxide. Chem. Res. Toxicol. 10, 672-676.
12. 1 exo-8,9-epoxide catalyzed by rat and human glutathione transferases: Estimation of kinetic parameters. Biochemistry 36, 3056-3060.
13. 1 exo-8,9-epoxide with DNA: Kinetic analysis of covalent binding and DNA-induced hydrolysis. Proc. Natl. Acad. Sci. USA 97, 6121-6125.
14. KENSLER, T.W., EGNER, P.A., DOLAN, P.M., GROOPMAN, J.D., and ROEBUCK, B.D. (1987). Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiole-3-thiones and 1,2-dithiole-3-ones. Cancer Res. 47, 4271-4277.
15. KENSLER, T.W., and HELZLSOUER, K.J. (1995). Oltipraz: Clinical opportunities for cancer chemoprevention. J. Cell. Biochem. 22S, 101-107.
16. KENSLER, T.W., GANGE, S.J., EGNER, P.A., et al. (1997). Predictive value of molecular dosimetry: Individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Cancer Epidemiol. Biomarkers Prev. 8, 603-610.
17. 1 metabolism in human hepatocytes in primary culture. Cancer Res. 55, 5574-5579.
18. LANGOUËT, S., MAHEO, K., BERTHOU, F., et al. (1997). Effects of administration of the chemoprotection agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. Carcinogenesis 18, 1343-1349.
19. LANGOUËT, S., MOREL, F., MEYER, D.J., et al. (1996). A comparison of the effect of inducers on the expression of glutathione S-transferases in the liver of the intact rat and in hepatocytes in primary culture. Hepatology 43, 881-887.
20. LUNN, R.M., ZHANG, Y.J., WANG, L.Y., et al. (1997). P53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 57, 3471-3477.
21. 1. Proc. Natl. Acad. Sci. USA 92, 2384-2387.
22. MAHEO, K., MOREL, F., LANGOUËT, S., et al. (1997). Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 57, 3649-3652.
23. MOREL, F., FARDEL, O., MEYER, D.J., et al. (1993). Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene and dithiolethiones. Cancer Res. 53, 231-234.
24. O'DWYER, P.J., SZARKA, C.E., YAO, K.S., et al. (1996). Modulation of gene expression in subjects at risk for colorectal cancer by the chemoprotective dithiolethione oltipraz. J. Clin. Invest. 98, 1210-1217.
25. QIAN, G.S., ROSS, R.K., YU, M.C., et al. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3, 3-10.
26. 1-8,9-epoxide and benzópyrene-7,8-dihydrodiol-9,10-epoxide. Toxicol. Appl. Pharmacol. 105, 216-225.
27. 1 exo and endo epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol. 5, 470-478.
28. NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci. USA 86, 462-465.
29. SHIMADA, T., ODA, Y., YAMAZAKI, H., MIMURA, M., and GUENGERICH, F.P. (1994). SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009, in Methods in Molecular Genetics, Vol. 5, Gene and Chromosome Analysis. Adolph, K.W. (ed.). pp. 342-355, Academic Press: Orlando, FL.
30. 1 by bacterial recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8, 218-225.
31. YEH, E.S., YU, M.C., MO, C.C., TONG, M.J., and HENDERSON, B.E. (1989). Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49, 2506-2509.
32. ZHANG, Y., KENSLER, T.W., CHO, C.G., POSNER, G., and TALALAY, P. (1994). Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. USA 91, 3147-3150.
33. ZHANG, Y., and TALALAY, P. (1994). Anticarcinogenic activities of organic isothiocyanates: Chemistry and mechanisms. Cancer Res. (Suppl.) 54, 1976s-1981s.
34. ZHOU, T., EVANS, A.A., LONDON, W.T., et al. (1997). Glutathione S-transferase expression in hepatitis B virus-associated human hepatocellular carcinogenesis. Cancer Res. 57, 2749-2753.